AMMONIA N 13 and OESOPHAGITIS

Overview

OESOPHAGITIS is the #16 most commonly reported adverse reaction for AMMONIA N 13, manufactured by 3D Imaging Drug Design and Development LLC. There are 4 FDA adverse event reports linking AMMONIA N 13 to OESOPHAGITIS. This represents approximately 1.5% of all 259 adverse event reports for this drug.

Patients taking AMMONIA N 13 who experience oesophagitis should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

OESOPHAGITIS is a less commonly reported adverse event for AMMONIA N 13, but still significant enough to appear in the safety profile.

Other Side Effects of AMMONIA N 13

In addition to oesophagitis, the following adverse reactions have been reported for AMMONIA N 13:

• DRUG ABUSE — 7 reports
• COUGH — 6 reports
• DEPRESSION — 6 reports
• CHEST PAIN — 5 reports
• DRUG INEFFECTIVE — 5 reports
• DYSPNOEA — 5 reports
• NAUSEA — 5 reports
• SUICIDE ATTEMPT — 5 reports
• VOMITING — 5 reports
• ACCIDENTAL EXPOSURE TO PRODUCT — 4 reports

Other Drugs Associated with OESOPHAGITIS

The following drugs have also been linked to oesophagitis in FDA adverse event reports:

Does AMMONIA N 13 cause OESOPHAGITIS?

OESOPHAGITIS has been reported as an adverse event in 4 FDA reports for AMMONIA N 13. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is OESOPHAGITIS with AMMONIA N 13?

OESOPHAGITIS accounts for approximately 1.5% of all adverse event reports for AMMONIA N 13, making it a notable side effect.

What should I do if I experience OESOPHAGITIS while taking AMMONIA N 13?

If you experience oesophagitis while taking AMMONIA N 13, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages